International Business News - DVAX http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Among the stock activity stories for Thursday, Sept. 18, from AP Financial News: CHICAGO (AP)--Shares of Pier 1 Imports Inc. climbed Thursday even after the home decor chain posted a worse-than-expected second-quarter loss and withdrew its previous guidance for 2009. http://www.ibtimes.com/articles/20080918/movers-roundup-pier-1-vertex-pharmaceuticals.htm Thu, 18 Sep 2008 14:29:03 EDT Shares of Dynavax Technologies Corp. fell Thursday as the biotechnology company responded to a Food and Drug Administration request for more information on a halted study of the developing hepatitis B vaccine Heplisav. http://www.ibtimes.com/articles/20080918/dynavax-shares-fall-after-issuing-fda-response.htm Thu, 18 Sep 2008 19:24:00 EDT Shares of General Electric Co. rose in premarket trading Friday after the company confirmed it plans to sell or spin-off its century-old appliance business. http://www.ibtimes.com/articles/20080516/premarket-movers-ge-rises-dynavax-falls.htm Fri, 16 May 2008 09:17:38 EDT Shares of Dynavax Technologies Corp. plummeted Friday after the drug developer said it is ending development of its ragweed allergy drug Tolamba after it failed a midstage trial. http://www.ibtimes.com/articles/20080516/dynavax-ends-development-of-allergy-drug-tolamba.htm Fri, 16 May 2008 09:52:15 EDT Wall Street is waiting to find out if a pause in testing a Hepatitis B vaccine by Dynavax technologies Corp. and Merck & Co. is a brief delay or a sign of greater trouble. http://www.ibtimes.com/articles/20080318/ahead-of-the-bell-dynavax.htm Tue, 18 Mar 2008 08:24:05 EDT Merck Inc. and Dynavax said Monday federal regulators have halted studies of their experimental hepatitis vaccine due to safety concerns. The Food and Drug Administration placed a hold on trials for the companies' Heplisav vaccine after one patient in the U.S. was diagnosed with a rare disease that causes blood vessels to inflame. http://www.ibtimes.com/articles/20080317/fda-halts-merck-dynavax-vaccine-studies.htm Mon, 17 Mar 2008 17:10:03 EDT Dynavax Technologies Corp. shares climbed Friday after an Oppenheimer analyst upgraded the stock, predicting approval and eventual success for Dynavax's hepatitis B vaccine candidate Heplisav. http://www.ibtimes.com/articles/20080222/out-of-the-gate-dynavax-up-on-upgrade.htm Fri, 22 Feb 2008 10:33:52 EST